CA3105829A1 - Bisphosphonate quinolone conjugates and uses thereof - Google Patents
Bisphosphonate quinolone conjugates and uses thereof Download PDFInfo
- Publication number
- CA3105829A1 CA3105829A1 CA3105829A CA3105829A CA3105829A1 CA 3105829 A1 CA3105829 A1 CA 3105829A1 CA 3105829 A CA3105829 A CA 3105829A CA 3105829 A CA3105829 A CA 3105829A CA 3105829 A1 CA3105829 A1 CA 3105829A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- substituted
- bone
- quinolone
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/548—Phosphates or phosphonates, e.g. bone-seeking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862695583P | 2018-07-09 | 2018-07-09 | |
US62/695,583 | 2018-07-09 | ||
PCT/US2019/041063 WO2020014269A1 (en) | 2018-07-09 | 2019-07-09 | Bisphosphonate quinolone conjugates and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3105829A1 true CA3105829A1 (en) | 2020-01-16 |
Family
ID=69142455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3105829A Pending CA3105829A1 (en) | 2018-07-09 | 2019-07-09 | Bisphosphonate quinolone conjugates and uses thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3820565A4 (ja) |
JP (1) | JP7501960B2 (ja) |
CN (1) | CN112672787A (ja) |
CA (1) | CA3105829A1 (ja) |
WO (1) | WO2020014269A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112533612A (zh) * | 2018-06-26 | 2021-03-19 | 弗兰克·哈洛克·埃比蒂诺 | 骨靶向抗微生物噁唑烷酮相关化合物、其制剂及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998015560A1 (en) | 1996-10-09 | 1998-04-16 | Elizanor Biopharmaceuticals, Inc. | Diphosphonate therapeutic compounds |
CN101300248A (zh) * | 2005-04-21 | 2008-11-05 | 塔甘塔治疗公司 | 膦酸酯化的氟喹诺酮、其抗菌类似物以及预防和治疗骨和关节感染的方法 |
BRPI0614758A2 (pt) | 2005-08-11 | 2011-04-12 | Targanta Therapeutics Inc | rifamicinas fosfonadas e usos destas para a prevenção e tratamento de infecções na articulação e osso |
-
2019
- 2019-07-09 CN CN201980058610.8A patent/CN112672787A/zh active Pending
- 2019-07-09 JP JP2021500846A patent/JP7501960B2/ja active Active
- 2019-07-09 CA CA3105829A patent/CA3105829A1/en active Pending
- 2019-07-09 EP EP19835178.5A patent/EP3820565A4/en active Pending
- 2019-07-09 WO PCT/US2019/041063 patent/WO2020014269A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3820565A4 (en) | 2022-04-06 |
JP7501960B2 (ja) | 2024-06-18 |
EP3820565A1 (en) | 2021-05-19 |
CN112672787A (zh) | 2021-04-16 |
JP2021532087A (ja) | 2021-11-25 |
WO2020014269A9 (en) | 2020-03-05 |
WO2020014269A1 (en) | 2020-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240182504A1 (en) | Bisphosphonate quinolone conjugates and uses thereof | |
Sedghizadeh et al. | Design, synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms | |
JP2022166008A (ja) | ビスホスホネート・キノロン複合体及びそれらの用途 | |
Hoefert et al. | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings | |
JP5368092B2 (ja) | ホスホン化リファマイシン類および骨と関節感染の予防と治療のためのその投与法 | |
JP2005519904A (ja) | コドラッグのコントロールデリバリ用ポリマー性ゲルシステム | |
WO2015009991A2 (en) | Methods, systems, and compositions for promoting bone growth | |
ES2322343T3 (es) | Compuesto fosfocalcico modificado, composicion inyectable que lo contiene. | |
Sedghizadeh et al. | Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications | |
JP7501960B2 (ja) | ビスホスホネート・キノロン複合体及びそれらの用途 | |
RU2360663C1 (ru) | Гель для регенерации костной ткани | |
DE19920247A1 (de) | Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung | |
JP2008536911A (ja) | ホスホン酸処理フルオロキノロン、その抗菌類似体および骨および関節感染の予防および治療方法 | |
EA038147B1 (ru) | Способы лечения периимплантита | |
US20210369849A1 (en) | Bone targeted antimicrobial oxazolidinone related compounds, formulations thereof, and uses thereof | |
DE19859668A1 (de) | Verwendung von Bisphosphonaten zur Prophylaxe und zur Behandlung von infektiösen Prozessen | |
JP2018002624A (ja) | 破骨細胞の形成または活性化抑制剤 | |
Kato | Biological profile of fast-setting calcium silicate-based cements: in vitro and ex vivo evaluation | |
Abdallah | Evaluation of a novel anabolic bone drug with synthetic bone graft biomaterials in a rat jaw bone defect | |
AU2005202737B2 (en) | Use of chemotherapeutic agents | |
Doering | Local targeting of anabolic drug conjugates for treatment of bone loss after tooth extraction | |
Jeppson | Antimicrobial properties of drug-containing electrospun scaffolds | |
Aboamo | Clinical and radiographic evaluation of simvastatin mixed with beta-tricalcium phosphate in the treatment of a periodontal Intra-bony defect | |
KR20090040513A (ko) | 세포재생용 조성물 |